Morphin Painbreak Akut Pb Pharma (Morphine Sulfate)

Morphine is an opioid analgesic used to manage pain pathways.

• Acute postoperative pain: provides rapid relief of pain following surgical procedures.
• Cancer‑related pain: controls moderate to severe pain associated with malignant disease.
• Chronic severe non‑cancer pain: alleviates persistent pain when other treatments are insufficient.

• Morphine sulfate acts as a full agonist at mu‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces calcium influx, and increases potassium efflux, leading to decreased neuronal excitability and diminished transmission of nociceptive signals, thereby producing analgesia.

Morphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: feeling of sickness often accompanied by vomiting.
• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Sweating: excessive perspiration unrelated to temperature.
• Dry mouth: reduced salivation causing a parched feeling.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Anaphylactic reaction: sudden, severe allergic response with rash, swelling, or airway compromise.
• Adrenal insufficiency: impaired cortisol production leading to fatigue and weakness.
• Seizures: rare occurrence of convulsive episodes.
• Dependence or addiction: development of physical or psychological reliance on the drug.

When prescribing or dispensing morphine, several safety considerations are essential.

• Assess pain severity: evaluate the intensity and cause of pain before initiating therapy.
• Evaluate respiratory function: monitor breathing, especially in patients with pulmonary disease.
• Monitor for dependence: watch for signs of tolerance, misuse, or addiction.
• Adjust dose in organ impairment: reduce dosage in renal or hepatic dysfunction.
• Avoid concurrent CNS depressants: limit use with benzodiazepines or alcohol.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Morphine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound respiratory depression.
• Monoamine oxidase inhibitors (MAOIs): increase risk of serotonin syndrome and hypertensive crisis.
• Respiratory depressants (e.g., anesthetic gases): potentiate breathing suppression.
• CYP3A4 inhibitors (e.g., ketoconazole): raise morphine plasma levels, heightening toxicity.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin): may reduce morphine effectiveness.
• Diuretics: can enhance hypotensive effects.
• Antihistamines and anticholinergics: may increase sedation and anticholinergic burden.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): raise risk of gastrointestinal bleeding.